July 27, 2022 Quanterix Launches First pTau-181 Plasma Laboratory Developed Test for Clinical Diagnostic and Research Applications in the U.S. read article
April 22, 2022 Quanterix Granted Breakthrough Device Designation from U.S. FDA for NfL Test for Multiple Sclerosis read article